ArticleCardiovascular and interventional radiology2021

Radiologic Response Combined with Dermatologic Toxicities is the Most Robust Predictor of Survival Benefits in Patients with Inoperable Hepatocellular Carcinoma After Transarterial Chemoembolization Plus Sorafenib Therapy.

Zhiqiu Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.